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Erratum
Claire C.J. Dekkers, David C. Wheeler, C. David Sjo¨stro¨m, Bergur V. Stefansson, Valerie Cain and
Hiddo J.L. Heerspink
Effects of the sodium–glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b–4 chronic kid-
ney disease,Nephrology Dialysis Transplantation, gfx350, https://doi.org/10.1093/ndt/gfx350
In the above article, the n numbers for the least squares mean values (LSM) reported below figure 2A were incorrect. The num-
bers forWeek 102 were repeated under the graph rather than displaying the true LSM values, which were 62 for placebo, 55 for dapa-
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